Combination Chemotherapy With or Without G-CSF in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Gini F. Fleming, MD
University of Chicago
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
73 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ncic-Clinical Trials Group
Kingston, Ontario, Canada
- University of Alabama Comprehensive Cancer Center
Birmingham, Alabama, United States
- Ccop - Greater Phoenix
Phoenix, Arizona, United States
- Jonsson Comprehensive Cancer Center, Ucla
Los Angeles, California, United States
- Usc/norris Comprehensive Cancer Center
Los Angeles, California, United States
- Chao Family Comprehensive Cancer Center
Orange, California, United States
- Women'S Cancer Center
Palo Alto, California, United States
- University of Colorado Cancer Center
Denver, Colorado, United States
- Vincent T. Lombardi Cancer Research Center, Georgetown University
Washington D.C., District of Columbia, United States
- Walter Reed Army Medical Center
Washington D.C., District of Columbia, United States
- H. Lee Moffitt Cancer Center and Research Institute
Tampa, Florida, United States
- Emory University Hospital - Atlanta
Atlanta, Georgia, United States
- Mbccop - Hawaii
Honolulu, Hawaii, United States
- Mbccop - University of Illinois at Chicago
Chicago, Illinois, United States
- Rush-Presbyterian-St. Luke'S Medical Center
Chicago, Illinois, United States
- University of Chicago Cancer Research Center
Chicago, Illinois, United States
- Ccop - Central Illinois
Decatur, Illinois, United States
- Ccop - Evanston
Evanston, Illinois, United States
- Indiana University Cancer Center
Indianapolis, Indiana, United States
- Ccop - Iowa Oncology Research Association
Des Moines, Iowa, United States
- University of Iowa Hospitals and Clinics
Iowa City, Iowa, United States
- Albert B. Chandler Medical Center, University of Kentucky
Lexington, Kentucky, United States
- Johns Hopkins Oncology Center
Baltimore, Maryland, United States
- Medicine Branch
Bethesda, Maryland, United States
- Radiation Oncology Branch
Bethesda, Maryland, United States
- Tufts University School of Medicine
Boston, Massachusetts, United States
- Memorial Hospital
Worcester, Massachusetts, United States
- University of Massachusetts Memorial Medical Center
Worcester, Massachusetts, United States
- Ccop - Ann Arbor Regional
Ann Arbor, Michigan, United States
- Barbara Ann Karmanos Cancer Institute
Detroit, Michigan, United States
- University of Minnesota Cancer Center
Minneapolis, Minnesota, United States
- University of Mississippi Medical Center
Jackson, Mississippi, United States
- Keesler Medical Center - Keesler Afb
Keesler Air Force Base, Mississippi, United States
- Ccop - Kansas City
Kansas City, Missouri, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Ccop - Montana Cancer Consortium
Billings, Montana, United States
- Ccop - Missouri Valley Cancer Consortium
Omaha, Nebraska, United States
- Ccop - Southern Nevada Cancer Research Foundation
Las Vegas, Nevada, United States
- Cooper Hospital/university Medical Center
Camden, New Jersey, United States
- Cancer Center of Albany Medical Center
Albany, New York, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 1998
- Primary completion
- 30 Jun 2004
- Completion
- —
- Last update posted
- 9 Jul 2013
- Registered enrollment
- 240
- Registry id
- NCT00003691
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.